Ebook

Pediatric Drugs Market Overview

A recent report highlights the promising growth prospects for the pediatric drugs segment over the next decade

Read More >>

Formulation Considerations for Pediatric Populations: Finding the Right Dosage Form for Better Adherence

To address the challenges of pediatric formulations, specialized technology platforms are often needed to provide ease of application and improve patient outcomes.

Read More >>

CASE STUDY - Masking A Bitter Pediatric  Drug Taste Via Microencapsulation

The powder formulation is stable in home environments, easy to administer and has flexible dosing variations for children over two and adults for whom a solid dosage form is not appropriate.

Read More >>

Customized Release Through Dispersed Dosage Formats: Driving Patient Acceptance and Therapeutic Performance 

Read more >>

 

 

Looking at Extractables and Leachables
Old problems still haunting today’s pharma and biopharma world.
Read More >>

Navigating Bioprocessing Risks
E&L Testing in Monoclonal Antibody Production
Read More >>

Enhancing Regulatory Compliance with E&L Analysis of Extensive Packaging Components
Read More >>

Regulatory Requirements for Pharmaceutical Extractables & Leachables
Drug regulators emphasize the importance of assessing and controlling extractables and leachables to ensure patient safety.
Read More >>

A Comprehensive Extractables & Leachables Study for the Fentanyl Transdermal System
Read More >>

Navigating the Nexus: Exploring Current Regulatory Trends in Pharmaceutical Extractables and Leachables
A comprehensive Q&A with the experts at Sannova Analytical.
Read More >>

Parenteral Drugs: A Growth Industry
Led by monoclonal antibodies (mAbs), the parenterals market is poised for continued growth in the years ahead.
Read More >>

How successful CDMO collaboration sets the foundation for sterile product success
A leading global CDMO dedicated to unlocking the potential sterile injectable
Read More >>

Annex 1 Sterile Manufacturing Requirements
Are you fulfilling Annex 1 sterile manufacturing requirements in the U.S.? You should be.
Read More >>

Liposomal and Nanoparticle Technology at Pfizer Melbourne
Specializing in oncology, anti-infective and complex formulations, Pfizer Melbourne provides end-to-end services from development through to commercial manufacture of sterile dosage forms.
Read More >>

A Brave New World of Data Integrity
How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.
Read More >>

Inside the Lab of the Future
The Lab of the Future Isn’t About Digital Tools. It’s Not Even About Labs.
Read More >>

How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
AI and ML are set to have a measurable impact on drug development, clinical trials, supply chain, and commercial and regulatory processes.
Read More >>

Improving Laboratory, Efficiency, Productivity & Compliance
Alan Marcus, Chief Growth Officer at LabVantage Solutions, discusses how the company enables its partners to make better decisions by offering products and services that improve laboratory efficiency and productivity, while enhancing data integrity and compliance.
Read More >>

Five Key Steps to Successful AI in the Lab
The efficiencies and insights of artificial intelligence (AI), machine learning (ML), predictive analytics, and other emerging technologies offer abundant opportunities to laboratories.
Read More >>

Quality Risk Management for Laboratory Operations
How modern CMOs are keeping up with stringent regulatory guidelines by embracing advanced laboratory information systems.
Read More >>

A Guide to Software-as-a-Service LIMS
This guide examines a third option that is gaining traction among laboratories of all sizes – from entry-level to enterprise: Software-as-a-Service (SaaS).
Read More >>

Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
Putting Pharma 4.0 principles into practice, and how a crucial foundation for doing so is the digitation of technology transfer in the life sciences enterprise.
Read More >>

Project Management:
The Secret Weapon in Effective Tech Transfer
Read More >>

Overcoming Stressors in Knowledge Transfer
Addressing overpromising, performance issues, and organizational alignment to foster successful collaboration.
Read More >>

Successful Technology Transfer
A conversation on technology transfer with the experts at Jubilant HollisterStier.
Read More >>

FDA's Quality Management Maturity Program
Why should CDMOs adhere to the new CDER's Rating System?
Read More >>

FDA 2023 Inspection Roadmap
Is "Readiness" in your annual objectives?
Read More >>

The Shift Toward US Pharmaceutical Manufacturing
Considerations in attaining the right global mix.
Read More >>

HPAPI Development & Manufacturing Trends
Safety, containment, and analysis of the highly potent compounds from development to commercialization.
Read More >>

Orphan Drug Development: A Pragmatic Approach to Developing a Rare Disease Drug
Challenges and considerations associated with the expedited development of orphan drugs, and how to successfully work through them.
Read More >>

Orphan Drug Designation in the US: Why does it matter
Investigating how and why small pharmas should get onboard to help develop medicines effective in the treatment of orphan diseases.
Read More >>

Emerging Trends in Inhaled Drug Delivery
Inhaled drug delivery continues to evolve with groundbreaking innovations in technology, materials, and personalized medicine.
Read More >>

Trends in Dry Powder Inhalers
An overview of advancements, challenges, and future prospects in the dry powder inhaler market.
Read More >>

From Spray Drying to Drug Product
Managing Particles for Optimal Delivery to the Lungs
Read More >>

Mitigate Risk by Conducting Filling Assessments During Formulation Development
Read More >>

That's About the Size of it
Particle sizing is critical in all forms of pharma products.
Read More >>

Navigating Uncertainties Through Supply Chain Management
How to best avoid sleepless nights for the supply chain practitioner
Read More >>

Strategic CDMO Partnering
Risk Management for Late-Stage Clinical Assets
Read More >>

FDA Watch
Is Your Supply Chain at Risk
Read More >>

Supply Chain Efficiency
A Q&A with Societal CDMO's Vice President of Supply Chain, Shazib Jamil
Read More >>

Reimagining the Future of Pharma Supply Chains
Confronting challenges ranging from surging demand for vital medical products to shortages of critical items. 
Read More >>

Analytical Science: Evolving and Adapting for Advanced Medicines
In the last 10 to 15 years, the pharmaceutical industry has made significant strides in leveraging the full potential of cell and gene therapies, as several products have successfully made it through clinical development to approval.
Read More >>

Analytical Considerations in the Lifecycle Management of Biologics
Biologics represent a growing sector of the pharmaceutical industry. They are medicinal products derived from various natural sources and extracted or produced by genetic engineering techniques or other technologies.
Read More >>

The Design of Experiments Approach to Analytical Method Development
The European Medicines Agency (EMA) defines the quality by design (QbD) approach as one that aims to ensure the quality of medicines by employing statistical, analytical, and risk-management methodology in the design, development and manufacturing of medicines.
Read More >>

Leveraging Novel Analytical Approaches for Advanced Therapies
Small molecule-based drugs were the primary choice of physicians for the treatment or prevention of disease, until monoclonal antibodies were added to their arsenal with the first approval in 1986
Read More >>

Parenteral Manufacturing Market Trends
Meeting the rapidly growing demand for parenteral products.
Read More >>

Thought Leadership Spotlight: Sterile Manufacturing
Alcami’s vice president of business development for parenteral services, Mike Babics, shares his insights on sterile manufacturing market trends.
Read More >>

Parenteral Market Trends
Growing pipeline of biologics and COVID vaccine production drive unprecedented growth.
Read More >>

Ensuring Pharma Manufacturing Quality
How today’s life sciences manufacturers can effectively monitor processes, integrate with sub-contractors and align with regulatory reporting requirements.
Read More >>

Biopharma Contract Manufacturing: Robust Growth Ahead
The biopharmaceutical contract manufacturing market, worth more than $6 billion in 2020, continues to grow at robust rates.
Read More >>

Industry Invests Billions in Parenteral Capabilities
Market opportunities have service providers making significant investments via acquisitions, expansion of services and capacities.
Read More >>

Connected Devices Selection
Considerations for a digital-first approach to data collection.
Read More >>

Connected Devices Power Clinical Trials with Better Data
How connected devices in clinical research provide better data and solutions for customized clinical trials.
Read More >>

Power Your Clinical Trials with Better Devices
The advanced therapy sector has experienced exponential growth in recent years related to the number of technologies and vendors entering the medical data devices market. Additionally, a need for more specific, higher-capability devices across multiple geographies has emerged for many clinical trial operations, owing, in part, to the increased uniqueness of the drugs and therapies undergoing development.
Read More >>

Power Your Clinical Trials with Better Data
As clinical trial sponsors face increasing pressure to deliver new treatments to market faster, connected digital medical devices are taking on a larger and more critical role. Creating a smart data strategy, with streamlined data collection and compliant reporting, requires strategic solutions that are automated, flexible, and fit-for-purpose.
Read More >>

Power Your Clinical Trials With Better Solutions
Digital health technologies are becoming more crucial as clinical trials become more patient-centric, spurring a proliferation in technologies geared toward advancing better, more streamlined remote data collection. Advancing technologies that are more familiar, easier to use, and better connected to one another represents a unique challenge for an industry that has, for decades, relied on rigid, highly structured on-site clinical trial designs.
Read More >>

Decentralized Oncology Trials
How digital health and COVID-19 are transforming cancer research
Read More >>

Advancing Glucose Data Collection
IQVIA Connected Devices delivers more data with deeper insights
Read More >>

IQVIA Continuous Glucose Monitoring
Enhancing glucose data collection and study participation
Read More >>

Considerations for Emerging Biopharma R&D Growth
Critical steps for effective trial planning and execution.
Read More >>

Leveraging COVID Best Practices to Elevate Drug Development Innovation
A retrospective look at how the industry aimed to maintain trial continuity—what worked well as is, what needed improvements and what’s here to stay.
Read More >>

How to Run Decentralized Clinical Trials in the Complex Web of Data Protection
Lessons learned from operationalizing hybrid DCT solutions across the globe.
Read More >>

CRO Industry Market Report
M&A, investments in capabilities, technology trends and regulatory frameworks for clinical trials today.
Read More >>

DATA AND TECHNOLOGY: The Key to Patient Centric Clinical Research
How this convergence of trends is transforming the trial experience and increasing efficiencies.
Read More >>

Patient-Centricity by Design
Improving patient engagement and retention while reducing burden with scalable, adaptable decentralized trials
Read More >>

Planning for Diversity
Could the FDA guidance’s focus on planning be the motivation that transforms diversity from a challenge to business as usual?
Read More >>

The Three D's of DCTs
How design, data and delivery enhance the patient experience.
Read More >>